Potent influence of bovine serum proteins in experimental dendritic cell-based vaccination protocols

Scandinavian Journal of Immunology

Volumn 58, Issue 1, 2003, Pages 43-50

  Toldbod, H E ^a   Agger, R ^a   Bolund, L ^a   Hokland, M ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; TUMOR ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; FEMALE; FETAL CALF SERUM; IMMUNITY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR IMMUNITY; VACCINATION;

ANIMALS; ANTIBODIES; BLOOD PROTEINS; CANCER VACCINES; CATTLE; CELL LINE; DENDRITIC CELLS; FEMALE; FETAL BLOOD; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; VACCINATION;

EID: 0038008542     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01267.x     Document Type: Article

References (20)

1. Ribas A, Butterfield LH, Hu B et al. Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice. Cancer Res 2000;60:2218-24.
2. Serody JS, Collins EJ, Tisch RM, Kuhns JJ, Frelinger JA. T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery. J Immunol 2000;164:4961-7.
3. Eggert AO, Becker JC, Ammon M et al. Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture. Eur J Immunol 2002;32:122-7.
4. Nestle FO, Alijagic S, Gilliet M et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32.
5. Kugler A, Stuhler G, Walden P et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med 2000;6:332-6.
6. Pickl WF, Majdic O, Kohl P et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol 1996;157:3850-9.
7. Inaba K, Inaba M, Romani N et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992;176:1693-702.
8. Agger R, Petersen MS, Toldbod HE et al. Characterization of murine dendritic cells derived from adherent blood mononuclear cells in vitro. Scand J Immunol 2000;52:138-47.
9. Wang XY, Kazim L, Repasky EA, Subjeck JR. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol 2001;166:490-7.
10. Kocikova A, Kolesaric A, Koszik F, Stingl G, Elbe-Burger A. Murine Langerhans cells cultured under serum-free conditions mature into potent stimulators of primary immune responses in vitro and in vivo. J Immunol 1998;161:4033-41.
11. Muller G, Muller A, Jonuleit H et al. Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches. J Invest Dermatol 2000;114:142-9.
12. Seliger B, Wollscheid U, Momburg F, Blankenstein T, Huber C. Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells. Cancer Res 2001;61:1095-9.
13. Lutz MB, Kukutsch N, Ogilvie ALJ et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999;223:77-92.
14. Petersen MS, Toldbod HE, Holtz S, Hokland M, Bolund L, Agger R. Strain-specific variations in the development of dendritic cells in murine bone-marrow cultures. Scand J Immunol 2000;51:586-94.
15. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monodonal antibodies. J Exp Med 1990;171:1753-71.
16. Axelsen NH. Handbook of Immunoprecipitation-in-Gel Techniques. Scand J Immunol 1983;17 (Suppl. 10).
17. Bohm W, Thoma S, Leithauser F, Moller P, Schirmbeck R, Reimann J. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas. J Immunol 1998;161:897-908.
18. Mackensen A, Drager R, Schlesier M, Mertelsmann R, Lindemann A. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother 2000;49:152-6.
19. Ostler T, Ehl S. A cautionary note on experimental artefacts induced by fetal calf serum in a viral model of pulmonary eosinophilia. J Immunol Methods 2002;268:211.
20. Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283:1183-6.